Seeking Alpha

Shares of Affymax (AFFY -9.1%) become unhinged with a sudden 17% nosedive before they track back...

Shares of Affymax (AFFY -9.1%) become unhinged with a sudden 17% nosedive before they track back up again. Much of the speculation over the company has centered on whether its anemia drug Peginesatide will land FDA approval.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs